中国学者近期发表的论文
1.	Arsenic Attenuates GLI Signaling, Increasing or Decreasing its Transcriptional Program in a Context-Dependent Manner. Author: Li B, Giambelli C, Tang B, Winterbottom E, Long J, Jin K, Wang Z, Fei DL, Nguyen DM, Athar M, Wang B, Subbarayan PR, Wang L, Rai P, Ardalan B, Capobianco AJ, Robbins DJ. Journal: Mol Pharmacol. 2016 Feb;89(2):226-32. doi: 10.1124/mol.115.100867. Epub 2015 Nov 16.    PubMed
2.	Substance P Enhances Keratocyte Migration and Neutrophil Recruitment through Interleukin-8. Author: Słoniecka M, Le Roux S, Zhou Q, Danielson P. Journal: Mol Pharmacol. 2016 Feb;89(2):215-25. doi: 10.1124/mol.115.101014. Epub 2015 Dec 8.    PubMed
3.	Structural Insights into the Pharmacophore of Vinca Domain Inhibitors of Microtubules. Author: Wang Y, Benz FW, Wu Y, Wang Q, Chen Y, Chen X, Li H, Zhang Y, Zhang R, Yang J. Journal: Mol Pharmacol. 2016 Feb;89(2):233-42. doi: 10.1124/mol.115.100149. Epub 2015 Dec 9.    PubMed
4.	Verbascoside Alleviates Pneumococcal Pneumonia by Reducing Pneumolysin Oligomers. Author: Zhao X, Li H, Wang J, Guo Y, Liu B, Deng X, Niu X. Journal: Mol Pharmacol. 2016 Mar;89(3):376-87. doi: 10.1124/mol.115.100610. Epub 2015 Dec 23.    PubMed
5.	Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling. Author: Wangpu X, Lu J, Xi R, Yue F, Sahni S, Park KC, Menezes S, Huang ML, Zheng M, Kovacevic Z, Richardson DR. Journal: Mol Pharmacol. 2016 May;89(5):521-40. doi: 10.1124/mol.115.103044. Epub 2016 Feb 19.    PubMed
6.	MicroRNA 335 is required for differentiation of malignant glioma cells induced by activation of cAMP/protein kinase A pathway. Author: Shu M, Zhou Y, Zhu W, Zhang H, Wu S, Chen J, Yan G. Journal: Mol Pharmacol. 2012 Mar;81(3):292-8. doi: 10.1124/mol.111.076166. Epub 2011 Dec 15.    PubMed
7.	Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways. Author: Zeng CW, Zhang XJ, Lin KY, Ye H, Feng SY, Zhang H, Chen YQ. Journal: Mol Pharmacol. 2012 Apr;81(4):578-86. doi: 10.1124/mol.111.076794. Epub 2012 Jan 17.    PubMed
8.	Agonist-dependent potentiation of vanilloid receptor transient receptor potential vanilloid type 1 function by stilbene derivatives. Author: Zhang X, Du XN, Zhang GH, Jia ZF, Chen XJ, Huang DY, Liu BY, Zhang HL. Journal: Mol Pharmacol. 2012 May;81(5):689-700. doi: 10.1124/mol.111.076000. Epub 2012 Feb 10.    PubMed
9.	Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo. Author: Zhao XQ, Xie JD, Chen XG, Sim HM, Zhang X, Liang YJ, Singh S, Talele TT, Sun Y, Ambudkar SV, Chen ZS, Fu LW. Journal: Mol Pharmacol. 2012 Jul;82(1):47-58. doi: 10.1124/mol.111.076299. Epub 2012 Apr 4.    PubMed
10.	DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth. Author: Deng R, Yang F, Chang SH, Tang J, Qin J, Feng GK, Ding K, Zhu XF. Journal: Mol Pharmacol. 2012 Aug;82(2):189-98. doi: 10.1124/mol.111.077271. Epub 2012 May 2.    PubMed

同类著名期刊名称 h-index CiteScore PHARMACOLOGICAL REVIEWS 210 34.40 TRENDS IN PHARMACOLOGICAL SCIENCES 201 20.10 ADVANCED DRUG DELIVERY REVIEWS 278 29.30 DRUG RESISTANCE UPDATES 100 23.60 PHARMACOLOGY & THERAPEUTICS 180 16.60 MEDICINAL RESEARCH REVIEWS 119 15.00 BRITISH JOURNAL OF PHARMACOLOGY 190 11.30 DRUG DISCOVERY TODAY 157 12.80 CLINICAL PHARMACOLOGY & THERAPEUTICS 173 8.50 PHARMACOLOGICAL RESEARCH 118 9.90

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 302024 CANCER RESEARCH 166575 Molecular Medicine Reports 165480 International Journal of Nanomedicine 165088 CANCER LETTERS 160237 JOURNAL OF ETHNOPHARMACOLOGY 142523 BIOMEDICINE & PHARMACOTHERAPY 141813 Theranostics 136796 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 136624 International Journal of Environmental Research and Public Health 134308